The Pharmacy Times® Alzheimer Disease Resource Center is a comprehensive resource for clinical news and expert insights on treatments for Alzheimer disease.
December 20th 2024
New mechanisms of action are proving more effective than ever, offering slowed progression.
Study: Machine Learning Can Predict Early Alzheimer Disease, But Has Racial, Ethnic Unfairness
January 5th 2024Although machine learning models demonstrate potential to improve early detection of Alzheimer disease, sample sizes that underrepresent ethnic and racial groups result in unfairness.
Read More
Cognitive Tests Via Smartphone Help Identify Early Amyloid Changes Associated With Alzheimer Disease
January 4th 2024The pattern for the diminished learning curve, associated with elevated amyloid levels, was consistent across 3 memory tasks, with strongest results for recalling digit-signs and groceries prices.
Read More
Clinical Overview: Comparison of Anti-Amyloid Monoclonal Antibodies for Alzheimer Disease
October 11th 2023Aducanumab, lecanemab, and donanemab are novel monoclonal antibodies designed to slow disease progression and hopefully have a positive impact in the field of Alzheimer disease management.
Read More